Showing results (111-120 of 226) with videos related to

Sort By:
Pageof 23
Cancers|February 15, 2022
Modeled Early Longitudinal PSA Kinetics Prognostic Value in Rising PSA Prostate Cancer Patients after Local Therapy Treated with ADT +/- DocetaxelAurore Carrot, Reza-Thierry Elaidi, Olivier Colomban, et al.
Journal of Clinical Medicine|November 13, 2021
Results of a 2021 French National Survey on Management of Patients with Advanced Stage Epithelial Ovarian CancerLeonor Drouin, Benedetta Guani, Vincent Balaya, et al.
JCO Clinical Cancer Informatics|February 16, 2024
Prognostic Value of the Modeled Prostate-Specific Antigen KELIM Confirmation in Metastatic Castration-Resistant Prostate Cancer Treated With Taxanes in FIRSTANAAurore Carrot, Stéphane Oudard, Olivier Colomban, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 3, 2023
Brachytherapy and surgery versus surgery alone for IB2 (FIGO 2018) cervical cancers: A FRANCOGYN studyOthman Aissaoui, Jérôme Phalippou, Abel Cordoba, et al.
Annals of Surgical Oncology|June 5, 2015
Intraperitoneal Vascular Endothelial Growth Factor: A Prognostic Factor and the Potential for Intraperitoneal Bevacizumab Use in Peritoneal Surface MalignanciesClaramae Shulyn Chia, Olivier Glehen, Naoual Bakrin, et al.
Human Reproduction (Oxford, England)|August 16, 2011
Contribution of referent pathologists to the quality of trophoblastic diseases diagnosisFrancois Golfier, Jessica Clerc, Touria Hajri, et al.
Annals of Surgery|May 15, 2012
Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosisGuillaume Passot, Delphine Vaudoyer, Eddy Cotte, et al.
European Journal of Cancer (Oxford, England : 1990)|September 4, 2019
Clinical efficacy of the optimal biological dose in early-phase trials of anti-cancer targeted therapiesPauline Corbaux, Mévidette El-Madani, Michel Tod, et al.
Journal of the National Cancer Institute|July 5, 2012
Quality of reporting of modern randomized controlled trials in medical oncology: a systematic reviewJulien Péron, Gregory R Pond, Hui K Gan, et al.
International Journal of Cancer|January 18, 2019
A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitorsPatrick Arnaud-Coffin, Denis Maillet, Hui K Gan, et al.
Pageof 23